Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Sernova Biotherapeutics Inc. (SEOVF) had Free Cash Flow per Share of $-0.02 for the most recently reported fiscal quarter, ending 2025-04-30.
| Income Statement Financials | |
-- |
|
$-2.66M |
|
-- |
|
-- |
|
$3.04M |
|
$-3.04M |
|
$0.41M |
|
$-2.63M |
|
$-2.63M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-3.04M |
|
$-3.01M |
|
328.49M |
|
328.49M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$2.05M |
|
$0.19M |
|
$0.68M |
|
$2.73M |
|
$16.41M |
|
$0.86M |
|
$0.86M |
|
$17.26M |
|
$-14.54M |
|
$-14.54M |
|
$-14.54M |
|
328.49M |
|
| Cash Flow Statement Financials | |
$-6.10M |
|
-- |
|
$3.27M |
|
$4.23M |
|
$1.41M |
|
$-2.83M |
|
$0.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.12 |
|
-- |
|
-- |
|
-0.06 |
|
-0.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.10M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
18.28% |
|
18.28% |
|
-97.51% |
|
19.43% |
|
$-0.04 |
|
|
Free Cash Flow per Share |
$-0.02 |
$-0.02 |
|